Affinergy
Durham
About Affinergy
Affinergy develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces in order to kickstart biology toward an intended outcome. Affinergy is focused on developing coatings and medical devices for the orthopedic and cardiovascular markets. Affinergy's technology was patented at Duke University and the company has been incubated at Becton Dickinson's research center in Research Triangle Park. Affinergy was awarded 2005 Innovation of the Year by Frost & Sullivan in the category of Medical Device Coatings.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $4.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2006)
- Website: affinergy.com
- Phone: 919-433-2200
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/affinergy-2421667 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.